Thyroid disorders represent one of the most common endocrine pathologies worldwide, with an increasing incidence of both benign nodular disease and thyroid malignancies¹. Thyroidectomy remains the definitive treatment for symptomatic benign conditions such as multinodular goiter, Graves’ disease, and compressive thyroid enlargement, as well as for malignant tumors including papillary, follicular, medullary, and anaplastic thyroid carcinoma².

The global rise in thyroid cancer incidence over the past two decades has been attributed to improved diagnostic modalities and increased detection of microcarcinomas³. Despite the generally favorable prognosis of differentiated thyroid carcinoma, surgical management plays a central role in disease control⁴. Total thyroidectomy is often recommended in malignant cases, whereas hemithyroidectomy or subtotal procedures may suffice for benign disorders⁵.

Although thyroid surgery is considered safe in experienced hands, complications remain a concern⁶. The most frequent postoperative complication is hypocalcemia resulting from transient or permanent hypoparathyroidism⁷. Recurrent laryngeal nerve (RLN) injury is another feared complication, potentially leading to hoarseness, airway compromise, and long-term vocal dysfunction⁸. Postoperative hemorrhage, though rare, may be life-threatening due to airway compression⁹.

The risk of complications is influenced by factors such as extent of surgery, underlying pathology, lymph node dissection, surgeon experience, and anatomical variations¹⁰. Malignant thyroid disease often necessitates more extensive surgical dissection and central neck node clearance, increasing the likelihood of parathyroid devascularization and nerve injury¹¹. In contrast, surgery for benign conditions is usually less radical, potentially reducing complication rates¹².

Recent studies have focused on intraoperative nerve monitoring, meticulous capsular dissection techniques, and early postoperative calcium monitoring to minimize morbidity¹³. However, comparative outcome data between benign and malignant thyroid disorders remain variable across institutions¹⁴.

Understanding differences in surgical outcomes between these groups is crucial for risk stratification, patient counseling, and healthcare planning¹⁵. Therefore, this study aims to compare operative characteristics and postoperative complications of thyroidectomy in benign versus malignant thyroid disorders.

MATERIALS AND METHODS

This prospective comparative study was conducted in the Department of General Surgery at a tertiary care teaching hospital over 24 months.

Study Population

A total of 200 patients undergoing thyroidectomy were included.

Inclusion Criteria

• Age ≥18 years
• Patients undergoing hemithyroidectomy or total thyroidectomy
• Histopathologically confirmed benign or malignant thyroid disease
• Patients providing informed consent

Exclusion Criteria

• Previous thyroid surgery
• Recurrent thyroid malignancy
• Pre-existing vocal cord palsy
• Known hypoparathyroidism
• Severe systemic comorbidities contraindicating surgery

Grouping

• Group A (Benign) – 120 patients
• Group B (Malignant) – 80 patients

Preoperative Evaluation

• Thyroid function tests
• Ultrasonography
• FNAC
• Indirect laryngoscopy
• Serum calcium levels

Surgical Procedure

Surgery was performed under general anesthesia. Capsular dissection technique was used. Identification and preservation of RLN and parathyroid glands were prioritized. Central neck dissection was performed in indicated malignant cases.

Postoperative Monitoring

• Serum calcium at 24 and 48 hours
• Vocal cord examination
• Monitoring for hematoma

Outcome Measures

• Operative time
• Length of hospital stay
• Hypocalcemia (transient/permanent)
• RLN palsy
• Hemorrhage
• Wound infection

Statistical Analysis

Data were analyzed using SPSS version 25. Quantitative data were expressed as mean ± SD. Chi-square test and independent t-test were applied. p < 0.05 was considered statistically significant.

RESULTS

Table 1: Demographic Distribution

Malignant group had older age distribution and relatively lower female predominance.

Table 2: Type of Surgery

Total thyroidectomy was significantly more common in malignant cases.

Table 3: Operative Time

Malignant cases required significantly longer operative duration (p<0.001).

Table 4: Hypocalcemia

Hypocalcemia was significantly higher in malignant cases.

Table 5: RLN Injury

Higher nerve injury incidence in malignant group.

Table 6: Hospital Stay

Malignancy associated with prolonged hospitalization.

DISCUSSION

This study demonstrates significantly higher postoperative complication rates in malignant thyroid disorders compared to benign conditions. The increased incidence of transient and permanent hypocalcemia in malignant cases correlates with previous reports by Lee et al.¹⁶ and Kim et al.¹⁷, who attributed higher rates to extensive dissection and central lymph node clearance.

Similarly, RLN injury was more prevalent in malignant thyroidectomy, consistent with findings from Bergenfelz et al.¹⁸ and Lombardi et al.¹⁹. These studies emphasize that tumor infiltration and nodal dissection increase risk of nerve trauma.

Operative time was significantly longer in malignant cases, aligning with findings from Lang et al.²⁰. Longer surgical duration likely reflects complexity of tumor resection and lymphadenectomy.

The overall complication rates in our benign group were comparable to large database analyses reported by Kandil et al.²¹. Advances in capsular dissection technique and nerve monitoring have reduced morbidity.

Hospital stay was prolonged in malignancy, consistent with findings by Medas et al.²². This may reflect need for calcium monitoring and drain management.

The study confirms that although thyroidectomy is safe, malignant disease carries increased operative risk. Careful surgical expertise and early complication detection are essential.

CONCLUSION

Thyroidectomy for malignant thyroid disorders is associated with longer operative time, higher incidence of hypocalcemia and RLN injury, and prolonged hospital stay compared to benign thyroid disease. Enhanced surgical precision and vigilant postoperative care are crucial in malignant cases.

REFERENCES

1. Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. Lancet. 2016;388(10061):2783-95.
2. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1-133.
3. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide. CA Cancer J Clin. 2018;68(6):394-424.
4. Filetti S, Durante C, Hartl D, Leboulleux S, Locati LD, Newbold K, et al. Thyroid cancer. Nat Rev Dis Primers. 2018;4:1-17.
5. National Comprehensive Cancer Network (NCCN). Thyroid carcinoma (Version 2023). NCCN Clinical Practice Guidelines in Oncology. 2023.
6. Dionigi G, Lavazza M, Wu CW, Kim HY, Liu X, Randolph GW. Recurrent laryngeal nerve injury in thyroid surgery. Updates Surg. 2017;69(4):401-10.
7. Edafe O, Antakia R, Laskar N, Uttley L, Balasubramanian SP. Systematic review and meta-analysis of predictors of post-thyroidectomy hypocalcaemia. Br J Surg. 2018;105(4):307-20.
8. Randolph GW, Dralle H, Abdullah H, Barczynski M, Bellantone R, Brauckhoff M, et al. Electrophysiologic recurrent laryngeal nerve monitoring during thyroid and parathyroid surgery. Laryngoscope. 2019;129(S1):S1-16.
9. Anuwong A, Ketwong K, Jitpratoom P, Sasanakietkul T, Duh QY. Safety and outcomes of the transoral endoscopic thyroidectomy vestibular approach. Ann Surg. 2016;264(3):456-62.
10. Bergenfelz A, Salem AF, Jacobsson H, Nordenström E. Risk of recurrent laryngeal nerve palsy in thyroid surgery. Br J Surg. 2016;103(9):1249-58.
11. Wang TS, Roman SA, Sosa JA. Postoperative complications after thyroidectomy for malignancy. Ann Surg Oncol. 2017;24(3):747-53.
12. Kandil E, Noureldine SI, Abbas A, Tufaro AP. The impact of surgical volume on thyroidectomy complications. Surgery. 2016;159(1):54-63.
13. Schneider R, Randolph GW, Sekulla C, Phelan E, Machens A, Dralle H. Continuous intraoperative nerve monitoring in thyroid surgery. World J Surg. 2018;42(7):2226-32.
14. Kim SY, Kim SM, Chang H, et al. Predictive factors for hypocalcemia after total thyroidectomy. Head Neck. 2017;39(7):1272-8.
15. Medas F, Canu GL, Erdas E, Calò PG. Complications after thyroid surgery: retrospective study. Gland Surg. 2017;6(5):512-8.
16. Lee YS, Nam KH, Chung WY, Chang HS, Park CS. Postoperative complications of thyroid cancer surgery. Surgery. 2017;161(1):131-8.
17. Kim WW, Chung SH, Ban EJ, Lee CR, Kang SW, Jeong JJ, et al. Incidence and risk factors of hypoparathyroidism after thyroidectomy. Ann Surg Treat Res. 2018;94(6):312-8.
18. Bergenfelz A, Jansson S, Kristoffersson A, Mårtensson H, Reihnér E, Wallin G, et al. Complications to thyroid surgery. World J Surg. 2019;43(2):406-13.
19. Lombardi CP, Raffaelli M, De Crea C, Sessa L, Salvatori M, Bellantone R. Complications in thyroid surgery for cancer. Surgery. 2017;161(1):146-52.
20. Lang BH, Wong KP, Wan KY. Risk factors for hypocalcemia after thyroidectomy. Ann Surg Oncol. 2016;23(6):1949-55.
21. Kandil E, Saeed A, Mohamed SE, Aslam R, Friedlander P. Recurrent laryngeal nerve monitoring in thyroid surgery: systematic review. J Am Coll Surg. 2016;222(5):904-17.
22. Medas F, Erdas E, Pisano G, Nicolosi A, Calò PG. Postoperative hematoma after thyroid surgery. Int J Surg. 2019;67:48-52.
23. Stack BC Jr, Bimston DN, Bodenner DL, Brett EM, Dralle H, Orloff LA, et al. American Association of Endocrine Surgeons guidelines for thyroidectomy. Otolaryngol Clin North Am. 2016;49(3):593-615.
24. Zhao WJ, Luo H, Zhou YM, Dai WY, Zhu JQ. Meta-analysis of recurrent laryngeal nerve injury in thyroid surgery. Medicine (Baltimore). 2019;98(17):e15283.
25. Grogan RH, Mitmaker EJ, Clark OH. The evolution of thyroid surgery. Ann Surg. 2017;265(1):142-50.